Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

NEW
STU:4E2 (USA)  
€ 5.65 (0%) Jul 10
At Loss
P/B:
3.12
Market Cap:
€ 590.95M ($ 674.75M)
Enterprise V:
€ 385.50M ($ 440.17M)
Volume:
0
Avg Vol (2M):
1.87K
Trade In:

Relmada Therapeutics Inc Operating Data

Relmada Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Relmada Therapeutics Inc (STU:4E2) Operating Data Charts